ArticlePloS one2026

Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison.

Mohammed H Al-Qahtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.